Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H I Scher

Showing results (21-30 of 220) with videos related to

Pageof 22
Sort By:
The Journal of Urology|August 1, 1994
A bladder cancer multi-institutional experience with total cystectomy for muscle-invasive bladder cancerH I Scher
Seminars in Oncology|October 1, 1990
Chemotherapy for invasive bladder cancer: neoadjuvant versus adjuvantH I Scher
Journal of the National Cancer Institute|April 21, 1993
Suramin: here to stay!?H I Scher
Cancer Investigation|January 1, 1985
Controversies in treatment of small cell carcinoma of the lungB Shank, H I Scher
Current Opinion in Oncology|May 1, 1995
Prostate cancer in the era of prostate-specific antigenH I Scher, S Fossa
The American Journal of Medicine|February 23, 1987
Bone metastases: pathogenesis, treatment, and rationale for use of resorption inhibitorsH I Scher, A Yagoda
Seminars in Surgical Oncology|September 1, 1992
Chemotherapy for urothelial tract malignancies: breaking the deadlockH I Scher, L Norton
Urology|March 4, 2000
Clinical states in prostate cancer: toward a dynamic model of disease progressionH I Scher, G Heller
Current Opinion in Oncology|May 1, 1993
Incorporating tumor biology into therapy for prostate cancerJ Bromberg, H I Scher
Psycho-Oncology|May 20, 1998
Sertraline relieves hot flashes secondary to medical castration as treatment of advanced prostate cancerA J Roth, H I Scher
Pageof 22

Showing results (21-30 of 220) with videos related to

Sort By:
Pageof 22
The Journal of Urology|August 1, 1994
A bladder cancer multi-institutional experience with total cystectomy for muscle-invasive bladder cancerH I Scher
Seminars in Oncology|October 1, 1990
Chemotherapy for invasive bladder cancer: neoadjuvant versus adjuvantH I Scher
Journal of the National Cancer Institute|April 21, 1993
Suramin: here to stay!?H I Scher
Cancer Investigation|January 1, 1985
Controversies in treatment of small cell carcinoma of the lungB Shank, H I Scher
Current Opinion in Oncology|May 1, 1995
Prostate cancer in the era of prostate-specific antigenH I Scher, S Fossa
The American Journal of Medicine|February 23, 1987
Bone metastases: pathogenesis, treatment, and rationale for use of resorption inhibitorsH I Scher, A Yagoda
Seminars in Surgical Oncology|September 1, 1992
Chemotherapy for urothelial tract malignancies: breaking the deadlockH I Scher, L Norton
Urology|March 4, 2000
Clinical states in prostate cancer: toward a dynamic model of disease progressionH I Scher, G Heller
Current Opinion in Oncology|May 1, 1993
Incorporating tumor biology into therapy for prostate cancerJ Bromberg, H I Scher
Psycho-Oncology|May 20, 1998
Sertraline relieves hot flashes secondary to medical castration as treatment of advanced prostate cancerA J Roth, H I Scher
Pageof 22